The University’s School of Biosciences is to play a major role in a global project to develop new drugs to combat parasites.<\/p>\n
A Kent-based team led by Professor David Brown<\/a>\u00a0will be part of a four-year, multi-centre research programme funded by the European Union. The programme will focus on neglected parasitic diseases (NPDs) – classified as ‘neglected’ because investment in finding cures for these illnesses is extremely low, despite their devastating impact on human and veterinary health. A cause of this drug development standstill is a lack of financial incentive and low return on investment for the pharmaceutical industry.<\/p>\n The project titled PDE4NPD (PhosphoDiEsterase inhibitors to target Neglected Parasitic Diseases) will focus specifically on Chagas\u2019 disease, human African trypanosomiasis, leishmaniasis and schistosomiasis.<\/p>\n Professor Brown is Programme Director for the MSc Drug Design<\/a>. Further information about the project and its global academic and industrial\u00a0partners can be found here.<\/a><\/p>\n <\/p>\n